6185 on Hong Kong Stock Exchange

CanSino Biologics

Logo: CanSino Biologics, Public domain, via Wikimedia Commons3

Chinese vaccine company

CanSino Biologics (simplified Chinese: 康希诺生物; traditional Chinese: 康希諾生物; pinyin: Kāngxīnuò Shēngwù), often abbreviated as CanSinoBIO, is a Chinese vaccine company.2 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 16, 2026.

Overview

2009Founded1

Compare with another stock.

  • Ticker6185 on Hong Kong Stock Exchange1
  • Industrypharmaceutical industry1
  • HeadquartersTianjin1
  • Founded inTianjin1
  • Websitewww.cansinotech.com

See how the biggest companies compare on our leaderboards

CanSino Biologics (simplified Chinese: 康希诺生物; traditional Chinese: 康希諾生物; pinyin: Kāngxīnuò Shēngwù), often abbreviated as CanSinoBIO, is a Chinese vaccine company.2

How it started

History

CanSino Biologics was founded in 2009 in Tianjin by Yu Xuefeng, Zhu Tao, Qiu Dongxu and Helen Mao Huihua.

In July 2018, it filed an application to list on the Hong Kong Stock Exchange. It debuted on 28 March 2019 with an increase of 59%, the highest first day trading gain in Hong Kong since 2017. In August 2020, it completed a secondary offering on Shanghai Stock Exchange's STAR market where it raised 5.2 billion yuan (US$750 million).

From Wikipedia’s article on CanSino Biologics, shared under CC BY-SA 4.0.2

Timeline

  1. Mar 28, 2019Went public Listed on Hong Kong Stock Exchange1
  2. 2009Founded Founded in Tianjin1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3